glp 1 drug class Table from Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists Review Upcoming wave of hormone-based therapies
Description
This is due to its dual mechanism of action on the hormones involved in blood glucose control and achieving better metabolic results
Patient out-of-pocket costs of USD 200 to USD 500 monthly drive the 68% GLP-1 drug discontinuation rate in real-world adherence studies within the first 12 months of therapy
Some clients tell me that, after taking a GLP-1, it is the first time *ever* in their life that they experienced the sensation of fullness
2013;166(240249):e241
MDWatch has truly changed my life
These symptoms are typically mild to moderate, occur most frequently during dose titration, and often improve with continued treatment
